Testosterone Study
We are seeking approximately 75 male participants aged 28–65 to take part in a 28-day research study evaluating Qualia Testosterone+, a dietary supplement designed to support healthy testosterone levels and male vitality.
This is a randomized, double-blind, placebo-controlled study, meaning participants will be randomly assigned to receive either Qualia Testosterone+ or a placebo, and neither participants nor researchers will know which product was received until after the study ends.
Participants will take 3 capsules daily in the morning, with or without food, for 28 days.
The study will require two in-person blood draws at a local lab facility. All lab costs are covered by Qualia Life Sciences.
Upon completion of all study requirements, participants will receive a $300 credit at Qualia Life Sciences.
*US only
*This study is being conducted by Qualia Life Sciences
Pre-screening surveys are used solely to determine eligibility for participation.
Data will be securely stored on Qualia Life Sciences servers, accessible only to authorized personnel.
A final follow-up survey will be sent to collect additional feedback and reviews that may be featured in our marketing materials.
Inclusion Criteria
- Provide voluntary, written, informed consent to participate in the study
- Agree to provide a valid cell phone number and are willing to receive communications through text
- Can read and write English
- Willing to not begin taking any new supplements during the study and continue taking any supplements they are currently using regularly
- Willing to complete questionnaires, records, and diaries associated with the study
- Male participants aged 28–65
- A ≤500 ng/dL Total Testosterone at baseline
- Willing and able to visit a local blood draw facility for required blood sample collections
- Live within 20 miles of a suitable blood draw facility
- Willing to not consume any supplements containing Testosterone or botanicals known to impact hormones starting about 2 weeks prior to the baseline blood test and continuing through the intervention period
Exclusion Criteria
- Known food intolerances/allergy to any ingredients in the product
- Having any of the following conditions: Psychiatric conditions, neurologic disorders, endocrine disorders, cancer
- Having had a significant cardiovascular event in the past 6 months
- Taking MAO inhibitors, SSRIs, blood thinners, or any other psychiatric or neurological medicines
- On immunosuppressive therapy
- Individuals who were deemed incompatible with the test protocol
- Adults lacking capacity to consent
- Female
- Have Hypogonadism
- On Testosterone Replacement Therapy
- Taking Gonadotropin-releasing hormone (GnRH) injections or gonadotropins (hCG or FSH)